Allogene Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Allogene Therapeutics, Inc. has filed 570 SEC EDGAR filings since 19 Apr 2018

SEC filing history

Showing 326-350 of 570 matching filings.

Per page
25
Current page
14
4

PRIMARY DOCUMENT

Filing date
25 Mar 2022
Reporting date
23 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Mar 2022
Reporting date
23 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Mar 2022
Reporting date
15 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Mar 2022
Reporting date
15 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Mar 2022
Reporting date
15 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Mar 2022
Reporting date
15 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Mar 2022
Reporting date
15 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Mar 2022
Reporting date
07 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-262923

S-8

Filing date
23 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90685

SC 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90685

SC 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90685

SEC SCHEDULE 13G

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90685

SEC SCHEDULE 13G

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90685

SC 13G/A filing

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 - ALLOGENE THERAPEUTICS, INC.

Filing date
21 Jan 2022
Reporting date
12 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90685

AMENDED SC13D

Filing date
18 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jan 2022
Reporting date
12 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jan 2022
Reporting date
12 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-227333

CT ORDER filing

Filing date
25 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .